Life Sciences & Medicine

  • AB25 2ZD

Impacts

Aberdeen research prompts change in dental policy benefiting thousands of Scottish children

Craig Robert Ramsay (Coordinator), Jeremy M Grimshaw (Coordinator), Graeme Stewart MacLennan (Coordinator), Jan Clarkson (Coordinator), Nigel B. Pitts (Coordinator), Ruth Elizabeth Thomas (Coordinator), Elizabeth A Shirran (Coordinator), Marion Kay Campbell (Coordinator), Jill Ann Mollison (Coordinator)

Impact

Influencing national and international breastfeeding care through the generation of high quality evidence

Pat Hoddinott (Coordinator), David John Godden (Coordinator), Rosemary Jane Britten (Coordinator), Jill Ann Mollison (Coordinator), Amanda Jane Lee (Coordinator), Gordon Prescott (Coordinator), Anne Ludbrook (Coordinator)

Impact

Commercial applications of pioneering research on the human gut microbiota

Karen Patricia Scott (Participant), Petra Gisela Helen Louis (Participant), Alan Walker (Participant), Sylvia Helen Duncan (Participant), Harry James Flint (Participant)

Impact: Economic Impacts, Quality of life Impacts

Inorganic arsenic in rice bran and its products are an order of magnitude

Pete Smith (Coordinator), Jon Hillier (Coordinator), Joanne Ursula Smith (Coordinator)

Impact: Quality of life Impacts

Discovery and commercialisation of new drug for rheumatoid arthritis and related conditions

Iain Robert Greig (Coordinator), Stuart Ralston (Coordinator), Rob. J. van't Hof (Coordinator)

Impact